Key result
Biopsy proteomics reveals ~55 proteins that distinguish AL from ATTR cardiac amyloidosis.
Why the study?
What are the distinct and shared proteomic and molecular network signatures in endomyocardial biopsies of patients with ALλ and ATTR cardiac amyloidosis compared with non-amyloidogenic controls?
Case-Control (n=51)
No
What are the distinct and shared proteomic and molecular network signatures in endomyocardial biopsies of patients with ALλ and ATTR cardiac amyloidosis compared with non-amyloidogenic controls?
Whole-biopsy proteomics and network analysis of human endomyocardial samples corroborate distinct pathogenic mechanisms in cardiac amyloidosis—vesicle-mediated uptake and mitochondrial/peroxisomal stress in ALλ versus massive extracellular matrix and complement accumulation in ATTR—while identifying candidate tissue biomarkers such as EPPK1, C1QTNF5, and ADORA3.
Answers are grounded in this paper and cite their sources.
Supports distinct ALλ/ATTR mechanisms in cardiac amyloidosis; leaves open biomarker validation before any clinical use.
and ATTR conditions, respectively. These findings corroborate previously proposed pathological mechanisms, namely, direct mitochondrial toxicity of light chain fibrils internalized via macropinocytosis and massive extracellular deposition of ATTR. Notably, protein quantification and network topology enabled the identification of potential disease markers. Although the selection criteria were robust, validation in larger cohorts is needed. Nevertheless, given the challenging accessibility of the analyzed samples, the proposed landscape of results provides a valuable resource to encourage further studies on cardiac amyloidosis.
No takes yet. Share an insight, caveat, or question.
Viganò et al. (2026) conducted a case-control in ALλ and ATTR cardiac amyloidosis (n=51). ALλ and ATTR cardiac amyloidosis vs. Non-amyloidogenic control heart explants (n=12) was evaluated on Differentially abundant proteins (DAPs) and network topological signatures in whole endomyocardial biopsies (p=<=0.00001). Proteomic analysis of endomyocardial biopsies identified 1,045 and 1,133 differentially abundant proteins in ALλ and ATTR cardiac amyloidosis vs controls, plus 55 subtype-distinguishing proteins.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: